The U.S. Food ​and Drug ‌Administration said on Friday ​it has ​approved Sanofi's blood ⁠cancer drug, ​Sarclisa, which ​can be given under the ​skin through ​a wearable injector, ‌offering ⁠multiple ...

Approval covers all current IV isatuximab indications and introduces the first oncology product labeled for both OBI and manual SC administration. IRAKLIA (NCT05405166) established noninferiority of ...

The new statutory guidance for schools, called Benedict’s Law, will also provide allergy safety training for teachers.

A metabolic disorder that leads to high levels of fat in the blood and life-threatening pancreatic complications now has its first FDA-approved medicine, an RNA-targeting therapy developed by Ionis ...

The acquisition adds new chronic care devices, combining Owen Mumford’s expertise with embecta’s commercial operations and manufacturing. Credit: Stock Photograph 3645 / Shutterstock.com. Embecta has ...

Owen Mumford, a medical device manufacturer based in Oxfordshire, has been acquired by US-listed Embecta Group in a deal worth up to £150 million. Owen Mumford’s devices cover injections, neuropathy, ...

Patent expiry across API, formulation, and device IP is expected to catalyze biosimilar competition, expanding access while compressing pricing across pharmaceutical and device value chains.

TORONTO — Health Canada has approved the first needle-free epinephrine treatment for severe allergic reactions: a nasal spray called neffy. ALK Canada, which purchased the rights to distribute the ...

A bill has passed the New Jersey Senate that would allow police officers to carry at least one dose of epinephrine auto-injector devices, or EpiPens. NJ Senate passes EpiPen bill allowing police to ...

Owen Mumford’s product suite includes autoinjectors and a range of medical devices for self-injection, pelvic health, testing. Credit: IM Imagery / Shutterstock.com. Embecta has signed a definitive ...

Embecta (Nasdaq:EMBC) announced today that it entered into a definitive agreement to acquire Owen Mumford Holdings Limited. Owen Mumford, a privately held, UK-based company, develops and manufactures ...

Lilly launches four-dose Zepbound KwikPen in the US. Self-pay starter price begins at $299 per month. Move aims to improve retention in crowded GLP-1 market. Millions of people on GLP-1 weight-loss ...